Skip to main content
. 2015 May 29;16(6):12261–12287. doi: 10.3390/ijms160612261

Table 1.

Toxicological studies using daphnia system in response to potential environmental stressors including endocrine disrupting chemicals (EDCs), heavy metals, organic compounds, pharmaceutical drugs, and nanoparticles.

Chemicals Species Chemical Exposure Effect Reference
EDCs Daphnia magna Nonylphenol at 0.024 mg/L for 48 h Abnormal proportion of juveniles [119]
Daphnia magna Juvenile hormone at 330 ng/L for 21 days Production of male offspring [121]
Ceriodaphnia dubia Styrene at 0.04–1.7 μg/L for 7 days Mortality and reduced fertility [120]
Daphnia magna Bisphenol A at 6.67 and 10 mg/L for 21 days Reduced offspring production [42]
Heavy metals Daphnia magna Cadmium at 6, 20, and 37 μg/L for 24 h Reduced survival and somatic growth [39]
Daphnia magna Cadmium chloride at 71 μg/L for 24 h Increased mortality, reduced survival, depleted glutathione level, and induced oxidative stress [75]
Ceriodaphnia dubia and Daphnia carinata Copper, lead, zinc (at 1.3, 1.1, 13.0 mg/L, respectively) for 48 h or 7 days Increased mortality and reduced reproduction ability [123]
Organic compounds Daphnia pulex Organic selenium at 0.025 mg/L for 48 h Death, immobility, and molting delay [122]
Daphnia magna Propiconazole (pesticide) at 1 μg/L for 4 and 8 days Impaired adult growth, decreased offspring development, impaired oocyte maturation, and interrupted resulting reproduction [41]
Daphnia magna Fenvalerate (insecticide) at 0.6 μg/L for 24 h Increased mortality, reduced survival, increased arginine phosphate level, and disrupted amino sugar metabolism [75]
Daphnia magna Uncoupler of oxidative phosphorylation 2,4-dinitrophenol at 1.5 mg/L for 24 h Increased mortality, reduced survival, and increased arginine phosphate level [75]
Daphnia magna Alkylpolyglucosides (GCP 650, GCP 600, GCP 215) at IC50 (29, 14, 111 mg/L, respectively) for 24 h Increased immobility [124]
Drugs Daphnia magna Ibuprofen (non-steroidal anti-inflammatory drug or NSAID) at 20, 40, 80 mg/L for 8 days Reduced fecundity and arrested early embryogenesis [104]
Daphnia magna Beta-blocker anti-hypertension drug propanolol at 1.4 mg/L for 24 h Increased mortality, reduced survival, and disrupted fatty acid metabolism and eicosanoid biosynthesis [75]
Daphnia magna Mefenamicacid at EC50 (17.16 mg/L) for 48 h and 1 mg/L for 21 days Increased immobility and reduced offspring production [125]
Nanoparticles Daphnia magna Silver nanoparticles with surface coating at LC50 (0.88 μg/L) for 48 h Increased mortality and reduced survival [126]
Daphnia magna Polyvinylpyrrolidone-coated silver nanoparticles at LC50 (0.18 mg/L) for 24 h Increased mortality, reduced survival, disrupted proteolysis and cell cycle [44]
Daphnia magna Coated silver nanoparticles (Ag-GAs, Ag-PEGs, and Ag-PVPs) at LC50 (3.41, 3.16, 14.81 μg/L, respectively) for 48 h Increased mortality [127]
Daphnia magna Collargol (protein-coated nano Ag) and AgNO3 nanoparticles at EC50 (20–27 ppb) for 48 h Increased immobility [128]
Daphnia magna Ag and CuO nanoparticles at EC50 (3.8 and 2.6 mg/L, respectively) for 24 h Increased immobility [129]
Daphnia magna Titanium dioxide nanoparticles at 0.01–10 mg/L for 48 h Reduced survival offspring production, and digestion ability [130]
Daphnia magna Nano and bulk titanium dioxide at 20 g/L for 48 h Undetectable toxicity [131]
Daphnia magna Bulk CuO, nano CuO and CuSO4 at L(E)C50 (165, 3.2, 0.17 mg/L, respectively) for 48 h Increased immobility [131]
Daphnia magna Bulk ZnO, nano ZnO and ZnSO4·7H2O at L(E)C50 (1.8, 1.9, 1.1 mg/L, respectively) for 48 h Increased immobility [131]